Nurix Therapeutics, Inc. NRIX Operating lease liabilities
Operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s operating lease liabilities?
- Nurix Therapeutics, Inc. (NRIX) reported operating lease liabilities of $205K in Q4 2025.
- How has Nurix Therapeutics, Inc.'s operating lease liabilities changed year-over-year?
- Nurix Therapeutics, Inc.'s operating lease liabilities increased by 112.2% year-over-year, from -$1.68M to $205K.
- What is the long-term trend for Nurix Therapeutics, Inc.'s operating lease liabilities?
- Over 4 years (2021 to 2025), Nurix Therapeutics, Inc.'s operating lease liabilities has grown at a -0.4% compound annual growth rate (CAGR), from -$5.14M to -$5.07M.